• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Normal range of calcitonin in children measured by a chemiluminescent two-site immunometric assay.

作者信息

Verga Uberta, Morpurgo Paola S, Vaghi Ivan, Radetti Giorgio, Beck-Peccoz Paolo

机构信息

Department of Medical Sciences, Endocrine Unit, University of Milan, Fondazione Policlinico, Mangiagalli e Regina Elena IRCCS, Milan, Italy.

出版信息

Horm Res. 2006;66(1):17-20. doi: 10.1159/000092848. Epub 2006 Apr 24.

DOI:10.1159/000092848
PMID:16636574
Abstract

Calcitonin (CT) assay is of considerable importance in the routine evaluation of thyroid nodules and for screening and follow-up of patients with medullary thyroid carcinoma and their relatives. Aim of this study was to assess the reference ranges for CT levels in healthy children and to evaluate possible differences in CT levels between sex and age. Serum CT levels were measured by a commercially available two-site chemiluminescence immunometric assay (sensitivity = 0.2 pg/ml). The ILMA recognizes the mature monomeric form of CT. We evaluated a cohort of 125 healthy children and compared these results with those from 98 healthy adult men and women. The ranges for human CT in children were <0.2-11.7 pg/ml and <0.2-17 pg/ml for female and male, respectively. No gender differences were observed in children population, though higher CT levels were observed in males. Serum CT levels did not correlate with age. Adult female had statistically significant lower CT levels than female children (p <or=0.05). In the adult population, males showed levels of CT higher than females. In conclusion, this study provide normal range for children population at different age with a sensible two-site chemiluminescent immunoassay. Since the normal range of serum CT levels is wider in healthy children than in adults, these data suggest establishing different normal range values in different age groups.

摘要

相似文献

1
Normal range of calcitonin in children measured by a chemiluminescent two-site immunometric assay.
Horm Res. 2006;66(1):17-20. doi: 10.1159/000092848. Epub 2006 Apr 24.
2
Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin.一种新型人降钙素化学发光双位点免疫测定法的临床应用价值
Exp Clin Endocrinol Diabetes. 1998;106(4):353-9. doi: 10.1055/s-0029-1211997.
3
Sensitive calcitonin measurement by two-site immunometric assays: implications for calcitonin screening in nodular thyroid disease.采用双位点免疫分析法定量检测降钙素:对结节性甲状腺疾病降钙素筛查的意义
Clin Lab. 2002;48(3-4):191-200.
4
[Katacalcin levels in healthy children and children with spasmophilia].[健康儿童和痉挛倾向儿童的降钙素水平]
Minerva Pediatr. 1989 Sep;41(9):459-66.
5
Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults.正常成年人中高剂量钙与五肽胃泌素对降钙素刺激的效能和耐受性比较。
J Clin Endocrinol Metab. 2009 Aug;94(8):2970-4. doi: 10.1210/jc.2008-2403. Epub 2009 Jun 2.
6
Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects.评估一种用于测定血清和血浆中C反应蛋白(CRP)的灵敏免疫发光测定法,并为不同组别的受试者建立参考范围。
Clin Lab. 2000;46(3-4):131-40.
7
[The extractable calcitonin value in normal individuals].[正常个体中可提取的降钙素值]
Nihon Seikeigeka Gakkai Zasshi. 1991 Oct;65(10):885-90.
8
Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer.对疑似甲状腺髓样癌患者进行细针穿刺时,测量针冲洗液中的降钙素。
Diagn Cytopathol. 2012 May;40(5):394-8. doi: 10.1002/dc.21731. Epub 2011 May 11.
9
Reference range of serum calcitonin in pediatric population.儿童人群血清降钙素的参考范围。
J Clin Endocrinol Metab. 2015 May;100(5):1780-4. doi: 10.1210/jc.2014-4508. Epub 2015 Mar 12.
10
Ghrelin in human medullary thyroid carcinomas.人甲状腺髓样癌中的胃饥饿素
Clin Endocrinol (Oxf). 2005 Oct;63(4):437-41. doi: 10.1111/j.1365-2265.2005.02360.x.

引用本文的文献

1
Gender-Dependent Reference Range of Serum Calcitonin Levels in Healthy Korean Adults.健康韩国成年人血清降钙素水平的性别依赖性参考范围。
Endocrinol Metab (Seoul). 2021 Apr;36(2):365-373. doi: 10.3803/EnM.2020.939. Epub 2021 Apr 7.
2
Development and application of a novel sensitive immunometric assay for calcitonin in a large cohort of patients with medullary and differentiated thyroid cancer, thyroid nodules, and autoimmune thyroid diseases.开发并应用新型降钙素敏感免疫分析测定法在大样本量的甲状腺髓样癌和分化型甲状腺癌、甲状腺结节和自身免疫性甲状腺疾病患者中的应用。
Eur Thyroid J. 2014 Jun;3(2):117-24. doi: 10.1159/000363055. Epub 2014 Jun 18.
3
Stimulated calcitonin cut-offs by different tests.
不同检测方法的降钙素激发 cut-offs。
Eur Thyroid J. 2013 Mar;2(1):49-56. doi: 10.1159/000346020. Epub 2013 Jan 16.
4
2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer.2012 年欧洲甲状腺协会关于甲状腺髓样癌基因检测及其临床后果的指南。
Eur Thyroid J. 2013 Jan;1(4):216-31. doi: 10.1159/000346174. Epub 2012 Dec 19.
5
Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).遗传性 C 细胞疾病基因携带者甲状腺手术的时机和范围——欧洲内分泌外科学会(ESES)的共识声明。
Langenbecks Arch Surg. 2014 Feb;399(2):185-97. doi: 10.1007/s00423-013-1139-5. Epub 2013 Dec 3.
6
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.多发性内分泌腺瘤病 2 型和家族性甲状腺髓样癌:更新。
J Clin Endocrinol Metab. 2013 Aug;98(8):3149-64. doi: 10.1210/jc.2013-1204. Epub 2013 Jun 6.
7
German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.德国内分泌外科学会恶性甲状腺肿瘤外科治疗指南。
Langenbecks Arch Surg. 2013 Mar;398(3):347-75. doi: 10.1007/s00423-013-1057-6. Epub 2013 Mar 3.
8
Multiple endocrine neoplasia type 2: achievements and current challenges.多发性内分泌肿瘤 2 型:成就与当前挑战。
Clinics (Sao Paulo). 2012;67 Suppl 1(Suppl 1):113-8. doi: 10.6061/clinics/2012(sup01)19.